$199 Million is the total value of CARNEGIE MELLON UNIVERSITY's 6 reported holdings in Q2 2022. The portfolio turnover from Q1 2022 to Q2 2022 was 0.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
NBSE | NEUBASE THERAPEUTICS INC | $986,000 | -44.2% | 939,412 | 0.0% | 0.50% | -32.9% | |
VERA | VERA THERAPEUTICS INCcl a | $219,000 | -41.9% | 16,060 | 0.0% | 0.11% | -30.4% | |
PREDICTIVE ONCOLOGY INC | $85,000 | -57.9% | 207,144 | 0.0% | 0.04% | -48.8% | ||
IHT | INNSUITES HOSPITALITY TRsh ben int | $29,000 | -6.5% | 10,000 | 0.0% | 0.02% | +15.4% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-08-05
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ISHARES INC | 8 | Q3 2023 | 79.8% |
DUOLINGO INC | 8 | Q3 2023 | 77.3% |
NEUBASE THERAPEUTICS INC. | 8 | Q3 2023 | 1.1% |
VERA THERAPEUTICS INC. | 8 | Q3 2023 | 0.4% |
PREDICTIVE ONCOLOGY INC. | 8 | Q3 2023 | 0.1% |
INNSUITES HOSPITALITY TRUST | 8 | Q3 2023 | 0.0% |
CARMELL THERAPEUTICS CORP | 1 | Q3 2023 | 0.5% |
View CARNEGIE MELLON UNIVERSITY's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
NeuBase Therapeutics, Inc. | July 22, 2019 | 939,412 | 5.5% |
View CARNEGIE MELLON UNIVERSITY's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-07 |
13F-HR | 2024-02-02 |
13F-HR | 2023-11-01 |
13F-HR | 2023-08-01 |
13F-HR | 2023-05-03 |
13F-HR | 2023-02-07 |
13F-HR | 2022-11-10 |
13F-HR | 2022-08-05 |
13F-HR | 2022-05-10 |
13F-HR | 2022-02-11 |
View CARNEGIE MELLON UNIVERSITY's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.